<https://w3id.org/codo#>	<http://purl.org/dc/terms/publisher>	"Indian Statistical Institute"@en .
<https://w3id.org/codo#>	<http://purl.org/dc/terms/modified>	"2023-07-11" .
<https://w3id.org/codo#>	<http://www.w3.org/2002/07/owl#versionIRI>	<https://w3id.org/codo/1.5> .
<https://w3id.org/codo#>	<http://purl.org/dc/terms/modified>	"2023-03-31" .
<https://w3id.org/codo#>	<http://purl.org/dc/terms/modified>	"2022-04-16" .
<https://w3id.org/codo#>	<http://purl.org/dc/terms/abstract>	"This specification describes CODO, an integrated ontological data model, a formal Ontology for collection and analysis of COVID-19 and related data. The Introduction section further provides the overall scope of the ontology and its usage. It is designed using W3C's RDF technology." .
<https://w3id.org/codo#>	<http://w3id.org/mod#browsingUI>	"https://w3id.org/codo" .
<https://w3id.org/codo#>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/2002/07/owl#Ontology> .
<https://w3id.org/codo#>	<http://purl.org/dc/terms/license>	"https://creativecommons.org/licenses/by/4.0/"^^<http://www.w3.org/2001/XMLSchema#anyURI> .
<https://w3id.org/codo#>	<http://purl.org/dc/terms/creator>	"Debanjali Bain"@en .
<https://w3id.org/codo#>	<https://w3id.org/mod#competencyQuestion>	"CQ 1: What mutations were discovered in patient p1's genomic testing results?\nCQ 2: Which patient's test result revealed the N501Y mutation?\nCQ 3: Which SARS-CoV-2 variant has patient p1 been diagnosed with?\nCQ 4: Which sequencing method was used in the genome sequencing test for patient p1?\nCQ 5: Who has been diagnosed as an Omicron patient?\nCQ 6: Which patients' nasopharyngeal swabs have been collected?\nCQ 7: A person's genomic sequence report reveals that the spike protein has a del69-70 mutation. Which variants might there be? \nCQ 8: What are the characteristic mutations found in the test result of a person (p2) diagnosed with the B.1.1.529 variant? \nCQ 9: What are all the substitution mutations that occurred in B.1.1.7?\nCQ 10: What mutations are detected in Delta?\nCQ 11: Where and when was the initial B.1.351 variant discovered?\nCQ 12: What structural proteins are present in SARS-CoV-2?\nCQ 13. Which therapeutics are recommended for COVID-19 patients with specific underlying health conditions? \nCQ 14. What are the potential adverse effects of specific COVID-19 drugs? \nCQ 15. Identify the drug interactions that may occur with a particular COVID-19 therapeutic.\nCQ 16. What are the risk factors associated with severe COVID-19 infection? \nCQ 17. How does the choice of COVID-19 therapeutics vary based on patient characteristics? \nCQ 18. Which drugs should be avoided due to known interactions with commonly prescribed COVID-19 medications?" .
<https://w3id.org/codo#>	<http://www.w3.org/ns/prov#preferredNamespacePrefix>	"codo"@en .
<https://w3id.org/codo#>	<http://purl.org/dc/terms/title>	"CODO: an Ontology for collection and analysis of COviD-19 data"@en .
<https://w3id.org/codo#>	<http://www.w3.org/2007/05/powder-s#describedby>	<http://localhost:8890/about/id/entity/http/www.isibang.ac.in/ns/codo> .
<https://w3id.org/codo#>	<http://www.w3.org/2007/05/powder-s#describedby>	<https://covidontheweb.inria.fr:4443/about/id/entity/http/www.isibang.ac.in/ns/codo> .
<https://w3id.org/codo#>	<http://purl.org/dc/terms/creator>	"Biswanath Dutta"@en .
<https://w3id.org/codo#>	<http://purl.org/dc/terms/created>	"2020-04-27" .
<https://w3id.org/codo#>	<http://www.w3.org/ns/prov#preferredNamespaceURI>	"https://w3id.org/codo" .